| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |